Engineered blood vessels could transform heart bypass surgery
NCT ID NCT07078370
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study tests a new lab-made blood vessel (ATEV) for use in coronary artery bypass surgery in 20 people with multi-vessel heart disease. The goal is to see if it is safe and can be successfully implanted as an alternative to using the patient's own veins. Researchers will monitor for heart-related complications and check if the vessel stays open over 12 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medicover
Warsaw, Poland
-
Military Institute of Medicine - National Research Institute
Warsaw, Poland
-
University Clinical Hospital No. 2 PUM in Szczecin
Szczecin, Poland
-
University Clinical Hospital in Poznań
Poznan, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which strategy wins for heart attack patients with multiple blocked arteries?
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?